Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-amylase activity	AMY1A AMY1B AMY1C	3.93e-07	5	69	3	GO:0004556
GeneOntologyMolecularFunction	amylase activity	AMY1A AMY1B AMY1C	7.84e-07	6	69	3	GO:0016160
GeneOntologyMolecularFunction	chloride ion binding	AMY1A AMY1B AMY1C	2.14e-05	16	69	3	GO:0031404
GeneOntologyMolecularFunction	AMPA glutamate receptor activity	GRIA2 GRIA4	7.03e-05	4	69	2	GO:0004971
GeneOntologyMolecularFunction	ATP-dependent activity	ATP13A4 ATP6V1G3 MYO9B NAE1 HELZ CHD1L ATP6V0D2 RFC3 RAD50	2.54e-04	614	69	9	GO:0140657
GeneOntologyMolecularFunction	sodium channel activity	SCN5A SCN8A GRIA2	7.73e-04	52	69	3	GO:0005272
GeneOntologyMolecularFunction	DNA helicase activity	CHD1L RFC3 RAD50	1.29e-03	62	69	3	GO:0003678
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP13A4 ATP6V1G3 ATP6V0D2	1.29e-03	62	69	3	GO:0019829
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	CACNA1E ATP13A4 ATP6V1G3 SCN5A SCN8A GRIA2 GRIA4 ATP6V0D2	1.40e-03	627	69	8	GO:0022890
GeneOntologyMolecularFunction	glutamate-gated receptor activity	GRIA2 GRIA4	1.55e-03	17	69	2	GO:0004970
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	CACNA1E ATP13A4 ATP6V1G3 SCN5A SCN8A GRIA2 GRIA4 ATP6V0D2 PEX5L	1.58e-03	793	69	9	GO:0015075
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	CACNA1E ATP13A4 ATP6V1G3 SCN5A SCN8A GRIA2 ATP6V0D2 PEX5L	2.01e-03	664	69	8	GO:0008324
GeneOntologyMolecularFunction	helicase activity	HELZ CHD1L RFC3 RAD50	2.19e-03	158	69	4	GO:0004386
GeneOntologyMolecularFunction	ATPase activity, coupled to transmembrane movement of ions, rotational mechanism	ATP6V1G3 ATP6V0D2	3.09e-03	24	69	2	GO:0044769
GeneOntologyMolecularFunction	proton-transporting ATPase activity, rotational mechanism	ATP6V1G3 ATP6V0D2	3.09e-03	24	69	2	GO:0046961
GeneOntologyMolecularFunction	ATPase-coupled ion transmembrane transporter activity	ATP6V1G3 ATP6V0D2	3.09e-03	24	69	2	GO:0042625
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	GRIA2 GRIA4	3.09e-03	24	69	2	GO:0099507
GeneOntologyMolecularFunction	voltage-gated sodium channel activity	SCN5A SCN8A	3.63e-03	26	69	2	GO:0005248
GeneOntologyMolecularFunction	glutamate receptor activity	GRIA2 GRIA4	3.91e-03	27	69	2	GO:0008066
GeneOntologyCellularComponent	node of Ranvier	SCN8A NFASC CNTN2	3.94e-05	20	70	3	GO:0033268
GeneOntologyCellularComponent	axon initial segment	SCN8A NFASC CNTN2	1.23e-04	29	70	3	GO:0043194
GeneOntologyCellularComponent	sodium channel complex	SCN5A SCN8A GRIA4	1.23e-04	29	70	3	GO:0034706
GeneOntologyCellularComponent	transmembrane transporter complex	CACNA1E ATP6V1G3 SCN5A SCN8A GRIA2 GRIA4 ATP6V0D2 PEX5L	3.52e-04	523	70	8	GO:1902495
GeneOntologyCellularComponent	transporter complex	CACNA1E ATP6V1G3 SCN5A SCN8A GRIA2 GRIA4 ATP6V0D2 PEX5L	4.92e-04	550	70	8	GO:1990351
Domain	Aamy_C	AMY1A AMY1C	7.80e-05	4	68	2	SM00632
Domain	Alpha_amylase	AMY1A AMY1C	7.80e-05	4	68	2	IPR006046
Domain	Alpha-amylase_C	AMY1A AMY1C	1.30e-04	5	68	2	PF02806
Domain	A-amylase/branching_C	AMY1A AMY1C	1.30e-04	5	68	2	IPR006048
Domain	Na_trans_cytopl	SCN5A SCN8A	1.94e-04	6	68	2	PF11933
Domain	Na_trans_cytopl	SCN5A SCN8A	1.94e-04	6	68	2	IPR024583
Domain	TPR-like_helical_dom	TTC28 HELZ PEX5L PRPF39 TTC6 LRP2BP	2.03e-04	233	68	6	IPR011990
Domain	Aamy	AMY1A AMY1C	2.71e-04	7	68	2	SM00642
Domain	Glyco_hydro_13_cat_dom	AMY1A AMY1C	2.71e-04	7	68	2	IPR006047
Domain	Alpha-amylase	AMY1A AMY1C	2.71e-04	7	68	2	PF00128
Domain	Na_channel_asu	SCN5A SCN8A	5.77e-04	10	68	2	IPR001696
Domain	Na_trans_assoc	SCN5A SCN8A	5.77e-04	10	68	2	IPR010526
Domain	Na_trans_assoc	SCN5A SCN8A	5.77e-04	10	68	2	PF06512
Domain	-	TTC28 HELZ PEX5L PRPF39 LRP2BP	9.43e-04	207	68	5	1.25.40.10
Domain	Channel_four-helix_dom	CACNA1E SCN5A SCN8A	1.17e-03	57	68	3	IPR027359
Domain	-	CACNA1E SCN5A SCN8A	1.17e-03	57	68	3	1.20.120.350
Domain	Glyco_hydro_b	AMY1A AMY1C	1.33e-03	15	68	2	IPR013780
Domain	Iontro_rcpt	GRIA2 GRIA4	1.92e-03	18	68	2	IPR001320
Domain	Lig_chan-Glu_bd	GRIA2 GRIA4	1.92e-03	18	68	2	PF10613
Domain	Iono_rcpt_met	GRIA2 GRIA4	1.92e-03	18	68	2	IPR001508
Domain	Glu/Gly-bd	GRIA2 GRIA4	1.92e-03	18	68	2	IPR019594
Domain	Lig_chan-Glu_bd	GRIA2 GRIA4	1.92e-03	18	68	2	SM00918
Domain	Lig_chan	GRIA2 GRIA4	1.92e-03	18	68	2	PF00060
Domain	PBPe	GRIA2 GRIA4	1.92e-03	18	68	2	SM00079
Domain	TPR-contain_dom	TTC28 PEX5L TTC6 LRP2BP	2.18e-03	150	68	4	IPR013026
Domain	TPR_REGION	TTC28 PEX5L TTC6 LRP2BP	3.08e-03	165	68	4	PS50293
Domain	TPR	TTC28 PEX5L TTC6 LRP2BP	3.08e-03	165	68	4	PS50005
Domain	IQ	MYO9B SCN5A SCN8A	3.22e-03	81	68	3	SM00015
Domain	TPR_1	TTC28 PEX5L TTC6	4.33e-03	90	68	3	PF00515
Domain	TPR_1	TTC28 PEX5L TTC6	4.33e-03	90	68	3	IPR001440
Domain	IQ_motif_EF-hand-BS	MYO9B SCN5A SCN8A	4.33e-03	90	68	3	IPR000048
Domain	IQ	MYO9B SCN5A SCN8A	4.74e-03	93	68	3	PS50096
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_	AMY1A AMY1B AMY1C	4.90e-06	9	56	3	M47622
Pathway	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE	AMY1A AMY1B AMY1C	9.58e-06	11	56	3	M1091
Pathway	REACTOME_DIGESTION	AMY1A AMY1B AMY1C	9.94e-05	23	56	3	M27790
Pathway	REACTOME_DIGESTION_AND_ABSORPTION	AMY1A AMY1B AMY1C	1.81e-04	28	56	3	M27837
Pathway	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	SCN5A SCN8A NFASC	2.47e-04	31	56	3	M877
Pubmed	AMY1 Gene Copy Number Correlates With Glucose Absorption and Visceral Fat Volume, but Not with Insulin Resistance.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	32697825
Pubmed	Evidence of duplication of the human salivary amylase gene.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	6176528
Pubmed	State and trait variance in salivary α-amylase: a behavioral genetic study.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	21827821
Pubmed	Salivary α-amylase copy number is not associated with weight trajectories and glycemic improvements following clinical weight loss: results from a 2-phase dietary intervention study.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	30982860
Pubmed	Structure of human salivary alpha-amylase at 1.6 A resolution: implications for its role in the oral cavity.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	15299664
Pubmed	Probing the role of a mobile loop in substrate binding and enzyme activity of human salivary amylase.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	12527308
Pubmed	Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	22063648
Pubmed	Salivary alpha amylase diurnal pattern and stress response are associated with body mass index in low-income preschool-aged children.	AMY1A AMY1B AMY1C	7.81e-09	3	70	3	25588701
Pubmed	Primary structure of human salivary alpha-amylase gene.	AMY1A AMY1B AMY1C	3.12e-08	4	70	3	2423416
Pubmed	Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1.	AMY1A AMY1B AMY1C	1.55e-07	6	70	3	6608795
Pubmed	Concerted evolution of human amylase genes.	AMY1A AMY1B AMY1C	1.55e-07	6	70	3	2452973
Pubmed	The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes.	AMY1A AMY1B AMY1C	1.55e-07	6	70	3	2788608
Pubmed	Evolution of the human alpha-amylase multigene family through unequal, homologous, and inter- and intrachromosomal crossovers.	AMY1A AMY1B AMY1C	1.55e-07	6	70	3	2081604
Pubmed	Detection of large-scale variation in the human genome.	AMY1A AMY1B AMY1C	1.55e-07	6	70	3	15286789
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	RCOR1 TTC28 NOP16 RBBP6 PCMTD2 RFC3 BIRC6 ARMC8 RAD50	4.29e-07	469	70	9	27634302
Pubmed	AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex.	AMY1A AMY1B AMY1C	4.34e-07	8	70	3	12414807
Pubmed	Two-hybrid analysis of human salivary mucin MUC7 interactions.	AMY1A AMY1B AMY1C	6.50e-07	9	70	3	16203048
Pubmed	HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.	TTC28 SSBP1 RFC3 BIRC6 ARMC8	9.28e-07	87	70	5	33711283
Pubmed	Salivary protein profiles are linked to bitter taste acceptance in infants.	AMY1A AMY1B AMY1C	1.27e-06	11	70	3	24248522
Pubmed	CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure.	SCN8A NFASC CNTN2	2.20e-06	13	70	3	15601927
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	STRN PELO TTC28 MYO9B RBBP6 USP11 HELZ CBX4 RAD50	2.76e-06	588	70	9	38580884
Pubmed	Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders.	GRIA2 GRIA4	3.99e-06	2	70	2	21984433
Pubmed	Copy number variation of human AMY1 is a minor contributor to variation in salivary amylase expression and activity.	AMY1A AMY1B	3.99e-06	2	70	2	28219410
Pubmed	Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.	GRIA2 GRIA4	3.99e-06	2	70	2	23613500
Pubmed	Genetic analysis of GRIA2 and GRIA4 genes in migraine.	GRIA2 GRIA4	3.99e-06	2	70	2	24512576
Pubmed	Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors.	ACVR2A RFC3 RAD50	5.20e-06	17	70	3	17456004
Pubmed	Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.	GRIA2 GRIA4	1.20e-05	3	70	2	22094384
Pubmed	Superactivation of AMPA receptors by auxiliary proteins.	GRIA2 GRIA4	1.20e-05	3	70	2	26744192
Pubmed	Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.	GRIA2 GRIA4	1.20e-05	3	70	2	22057216
Pubmed	A genetic interaction network model of a complex neurological disease.	SCN8A GRIA4	1.20e-05	3	70	2	25251056
Pubmed	Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients.	GRIA2 GRIA4	1.20e-05	3	70	2	18163426
Pubmed	Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities.	GRIA2 GRIA4	1.20e-05	3	70	2	30692144
Pubmed	Inherited hematological disorders due to defects in coat protein (COP)II complex.	MCFD2 SEC23B	1.20e-05	3	70	2	22764119
Pubmed	Eliminating Glutamatergic Input onto Horizontal Cells Changes the Dynamic Range and Receptive Field Organization of Mouse Retinal Ganglion Cells.	GRIA2 GRIA4	1.20e-05	3	70	2	29352045
Pubmed	Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder.	GRIA2 GRIA4	1.20e-05	3	70	2	22122651
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	RCOR1 PELO TTC28 RBBP6 USP11 SCN5A HELZ CBX4 RFC3 GGCX RAD50	1.35e-05	1116	70	11	31753913
Pubmed	In Vitro Identification of Histatin 5 Salivary Complexes.	AMY1A AMY1B AMY1C	2.21e-05	27	70	3	26544073
Pubmed	A phylogenetic analysis reveals an unusual sequence conservation within introns involved in RNA editing.	GRIA2 GRIA4	2.39e-05	4	70	2	10688364
Pubmed	Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland.	AMY1B AMY1C	2.39e-05	4	70	2	26132294
Pubmed	Characterization of the amino termini of mouse salivary and pancreatic amylases.	AMY1B AMY1C	2.39e-05	4	70	2	6165618
Pubmed	Multiple polyadenylation sites in a mouse alpha-amylase gene.	AMY1B AMY1C	2.39e-05	4	70	2	6166922
Pubmed	Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity.	AMY1B AMY1C	2.39e-05	4	70	2	26098870
Pubmed	Multiple structural genes for mouse amylase.	AMY1B AMY1C	2.39e-05	4	70	2	6160849
Pubmed	Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival.	GRIA2 GRIA4	2.39e-05	4	70	2	28608780
Pubmed	Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus.	AMY1B AMY1C	2.39e-05	4	70	2	4745489
Pubmed	AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus.	GRIA2 GRIA4	2.39e-05	4	70	2	9221927
Pubmed	Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse.	AMY1B AMY1C	2.39e-05	4	70	2	1141004
Pubmed	Genetic variation in mouse salivary amylase rate of synthesis.	AMY1B AMY1C	2.39e-05	4	70	2	94264
Pubmed	Interaction proteomics reveals brain region-specific AMPA receptor complexes.	GRIA2 GRIA4	2.39e-05	4	70	2	25337787
Pubmed	Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors.	GRIA2 GRIA4	2.39e-05	4	70	2	17828255
Pubmed	The two promoters of the mouse alpha-amylase gene Amy-1a are differentially activated during parotid gland differentiation.	AMY1B AMY1C	2.39e-05	4	70	2	3872721
Pubmed	Tissue-specific expression of mouse-alpha-amylase genes: nucleotide sequence of isoenzyme mRNAs from pancreas and salivary gland.	AMY1B AMY1C	2.39e-05	4	70	2	6157477
Pubmed	The N-terminal domain modulates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor desensitization.	GRIA2 GRIA4	2.39e-05	4	70	2	24652293
Pubmed	Electrophysiological properties of AMPA receptors are differentially modulated depending on the associated member of the TARP family.	GRIA2 GRIA4	2.39e-05	4	70	2	17409242
Pubmed	Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells.	AMY1B AMY1C	2.39e-05	4	70	2	2431276
Pubmed	Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation.	LIG4 RAD50	2.39e-05	4	70	2	18854157
Pubmed	Independent regulation of nonallelic pancreatic amylase genes in diabetic mice.	AMY1B AMY1C	2.39e-05	4	70	2	6207174
Pubmed	LARGE, an intellectual disability-associated protein, regulates AMPA-type glutamate receptor trafficking and memory.	GRIA2 GRIA4	2.39e-05	4	70	2	29915039
Pubmed	Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit.	GRIA2 GRIA4	2.39e-05	4	70	2	14561864
Pubmed	A 78-kilobase region of mouse chromosome 3 contains salivary and pancreatic amylase genes and a pseudogene.	AMY1B AMY1C	2.39e-05	4	70	2	2410924
Pubmed	A salivary amylase transgene is efficiently expressed in liver but not in parotid gland of transgenic mice.	AMY1B AMY1C	2.39e-05	4	70	2	2476716
Pubmed	Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1.	GRIA2 GRIA4	2.39e-05	4	70	2	10027300
Pubmed	A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs.	AMY1B AMY1C	2.39e-05	4	70	2	6162570
Pubmed	Additional evidence for the close linkage of amy-1 and amy-2 in the mouse.	AMY1B AMY1C	2.39e-05	4	70	2	6163812
Pubmed	Chromosomal localization of human glutamate receptor genes.	GRIA2 GRIA4	2.39e-05	4	70	2	1319477
Pubmed	AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks.	GRIA2 GRIA4	2.39e-05	4	70	2	12692557
Pubmed	Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini.	AMY1B AMY1C	2.39e-05	4	70	2	2987507
Pubmed	Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis.	GRIA2 GRIA4	2.39e-05	4	70	2	12125045
Pubmed	Termination of transcription in the mouse alpha-amylase gene Amy-2a occurs at multiple sites downstream of the polyadenylation site.	AMY1B AMY1C	2.39e-05	4	70	2	6091898
Pubmed	Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes.	AMY1B AMY1C	2.39e-05	4	70	2	2332419
Pubmed	Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction.	LIG4 RAD50	2.39e-05	4	70	2	11809878
Pubmed	The mouse alpha-amylase multigene family. Sequence organization of members expressed in the pancreas, salivary gland and liver.	AMY1B AMY1C	2.39e-05	4	70	2	6176715
Pubmed	Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences.	AMY1B AMY1C	2.39e-05	4	70	2	6162108
Pubmed	On the genetic polymorphism of the serum alpha-amylase in the population of the south western Bulgaria (second communication).	AMY1A AMY1B	2.39e-05	4	70	2	16152770
Pubmed	Unraveling genetic modifiers in the gria4 mouse model of absence epilepsy.	SCN8A GRIA4	2.39e-05	4	70	2	25010494
Pubmed	Genetic determination of amylase synthesis in the mouse.	AMY1B AMY1C	2.39e-05	4	70	2	6161122
Pubmed	AMPA receptor-mediated excitotoxicity in human NT2-N neurons results from loss of intracellular Ca2+ homeostasis following marked elevation of intracellular Na+.	GRIA2 GRIA4	2.39e-05	4	70	2	9648857
Pubmed	Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters.	AMY1B AMY1C	2.39e-05	4	70	2	3877171
Pubmed	Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked.	AMY1B AMY1C	2.39e-05	4	70	2	2989529
Pubmed	RNF220 is an E3 ubiquitin ligase for AMPA receptors to regulate synaptic transmission.	GRIA2 GRIA4	3.98e-05	5	70	2	36179027
Pubmed	Esterase-26 (ES-26): characterization and genetic location on chromosome 3 of an eserine-sensitive esterase of the house mouse (Mus musculus).	AMY1B AMY1C	3.98e-05	5	70	2	6529441
Pubmed	Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?	LIG4 RAD50	3.98e-05	5	70	2	23643835
Pubmed	Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries.	AMY1B AMY1C	3.98e-05	5	70	2	34276419
Pubmed	Altered salivary amylase gene in the mouse strain BXD-16.	AMY1B AMY1C	3.98e-05	5	70	2	6176569
Pubmed	RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.	GRIA2 GRIA4	3.98e-05	5	70	2	1717158
Pubmed	Early development of electrical excitability in the mouse enteric nervous system.	SCN5A SCN8A	3.98e-05	5	70	2	22875929
Pubmed	Structure of the murine tissue factor gene. Chromosome location and conservation of regulatory elements in the promoter.	AMY1B AMY1C	3.98e-05	5	70	2	1348427
Pubmed	Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites.	GRIA2 GRIA4	3.98e-05	5	70	2	16129400
Pubmed	Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.	SCN5A SCN8A	3.98e-05	5	70	2	17724025
Pubmed	Allosteric modulation of AMPA-type glutamate receptors increases activity of the promoter for the neural cell adhesion molecule, N-CAM.	GRIA2 GRIA4	3.98e-05	5	70	2	9482932
Pubmed	Molecular cloning and characterization of novel tissue-specific isoforms of the human vacuolar H(+)-ATPase C, G and d subunits, and their evaluation in autosomal recessive distal renal tubular acidosis.	ATP6V1G3 ATP6V0D2	3.98e-05	5	70	2	12384298
Pubmed	Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3.	AMY1B AMY1C	3.98e-05	5	70	2	8661735
Pubmed	Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF.	GRIA2 GRIA4	3.98e-05	5	70	2	15797551
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	CACNA1E PHPT1 NOP16 LAMA4 WDR89 GRIA2 HELZ SSBP1 TNMD RBM47 SEC23B	5.20e-05	1293	70	11	15342556
Pubmed	A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis.	AMY1B AMY1C	5.96e-05	6	70	2	7859283
Pubmed	Expression of calcyclin, a calcium-binding protein, in the keratogenous region of growing hair follicles.	AMY1B AMY1C	5.96e-05	6	70	2	2002257
Pubmed	Mapping and gene order of U1 small nuclear RNA, endogenous viral env sequence, amylase, and alcohol dehydrogenase-3 on mouse chromosome 3.	AMY1B AMY1C	5.96e-05	6	70	2	2450406
Pubmed	Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits.	GRIA2 GRIA4	5.96e-05	6	70	2	18922769
Pubmed	The spastic mouse: aberrant splicing of glycine receptor beta subunit mRNA caused by intronic insertion of L1 element.	AMY1B AMY1C	5.96e-05	6	70	2	7946325
Pubmed	Quantitative genetic analysis of brain copper and zinc in BXD recombinant inbred mice.	CACNA1E HPGD	5.96e-05	6	70	2	16910173
Cytoband	1p21	AMY1A AMY1B AMY1C	6.71e-06	24	70	3	1p21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p21	AMY1A AMY1B AMY1C	6.01e-04	107	70	3	chr1p21
Cytoband	4p14	NWD2 RBM47	1.90e-03	42	70	2	4p14
GeneFamily	Glutamate ionotropic receptor AMPA type subunits	GRIA2 GRIA4	3.31e-05	4	43	2	1200
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN5A SCN8A	1.97e-04	9	43	2	1203
GeneFamily	V-type ATPases	ATP6V1G3 ATP6V0D2	1.35e-03	23	43	2	415
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC28 PEX5L TTC6	2.57e-03	115	43	3	769
GeneFamily	Fibronectin type III domain containing	NFASC NCAM2 CNTN2	6.48e-03	160	43	3	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NFASC NCAM2 CNTN2	6.59e-03	161	43	3	593
ToppCell	Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENO4 UNC119B ATP13A4 ATP6V1G3 FMO2 GRIA4	5.08e-08	127	70	6	556aaf88719c83f307fa50dfac151136ed05c8ad
ToppCell	Control-Epithelial_alveolar-Mes-Like\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENO4 ATP13A4 ATP6V1G3 FMO2 GRIA4	1.11e-06	116	70	5	df7609503782d8d7e4f31ed2a626916e5474d5bc
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E CD3G SCN8A WDR89 GRIA2	1.11e-05	186	70	5	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	FMO2 TTC28 LAMA4 NFASC NCAM2	1.40e-05	195	70	5	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Biopsy_Control_(H.)-Epithelial-Basal\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ATP6V1G3 FMO2 GRIA2 EYA2 TTC6	1.54e-05	199	70	5	6a274a5db02c55bbf31d602b9d5c8394241acdca
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC119B MGAT4A CNTN2 LRP2BP	5.42e-05	131	70	4	419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCell	MS-CD4-CD8_2\|MS / Condition, Cell_class and T cell subcluster	ATP13A4 PELO ZNF280D MGAT4A	8.94e-05	149	70	4	08fb6be5599c5988890c851ce5ac6781c319948e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SCN5A NCAM2 PEX5L CNTN2	1.02e-04	154	70	4	30cb4bb297fa815adb829f3b5cafca56fcbcb810
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SCN5A NCAM2 PEX5L CNTN2	1.02e-04	154	70	4	ade094e2947761a0a34daa8fcff3e9ea8437e4a5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SCN5A NCAM2 PEX5L CNTN2	1.02e-04	154	70	4	42bd8f88fd075a2d4edde394785decad88a2660a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SCN5A NCAM2 PEX5L CNTN2	1.02e-04	154	70	4	6425d9861148586466febd6eceae1b1f9b9a14c1
ToppCell	facs-Lung-Endomucin-3m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3G CHD1L EYA2 CNTN2	1.18e-04	160	70	4	5c68d6a76c59e3a7e668ae5471396478a55756ac
ToppCell	facs-Lung-Endomucin-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3G CHD1L EYA2 CNTN2	1.18e-04	160	70	4	0fee84844733d36805e1df90ca09478169746708
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCN5A LAMA4 SYN2 GRIA2	1.32e-04	165	70	4	347b59aa625a8a960828b8620824d8ac48990e07
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCN5A LAMA4 SYN2 GRIA2	1.32e-04	165	70	4	507c89ece0a336b8e9c65b79889a714e17ddca27
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCN5A LAMA4 SYN2 GRIA2	1.32e-04	165	70	4	39a25be081a5d59c7cf107a997d352793d5025fb
ToppCell	PND03-Endothelial-Endothelial_lymphatic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCN5A LAMA4 SYN2 GRIA2	1.32e-04	165	70	4	1890f9c33b0c5b381d57f97042da2610a093a6de
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1E NFASC GRIA2 PEX5L	1.45e-04	169	70	4	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMS22L CD3G EYA2 NUDT15	1.59e-04	173	70	4	de124fb7ded04664d4184bf12f1f201c0784f07c
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1G3 LAMA4 ATP6V0D2 MMP20	1.73e-04	177	70	4	6d89042bda8e244babb68929e84b25edcb545a77
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1G3 LAMA4 ATP6V0D2 MMP20	1.73e-04	177	70	4	daaccf1249dcf816df4caca695a944f53078291a
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1G3 LAMA4 ATP6V0D2 MMP20	1.73e-04	177	70	4	338bdda26796bf4e16072878c070212d1006cf57
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1G3 LAMA4 ATP6V0D2 MMP20	1.73e-04	177	70	4	c5a16f984c836dbf7d0faf061677844167ab612a
ToppCell	wk_15-18-Epithelial-PNS-KCNIP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NWD2 SYN2 NFASC NCAM2	1.81e-04	179	70	4	e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NWD2 SYN2 NFASC PEX5L	1.81e-04	179	70	4	af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FMO2 NWD2 GRIA2 PEX5L	1.89e-04	181	70	4	092a971661b0aa06c1cdf428dbfa7339a26fb678
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	SCN8A SYN2 GRIA2 PEX5L	1.93e-04	182	70	4	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFASC GRIA2 PEX5L TNMD	2.01e-04	184	70	4	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NFASC GRIA2 PEX5L TNMD	2.01e-04	184	70	4	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD3G USP11 HPGD MGAT4A	2.05e-04	185	70	4	847257d232b9993cad50c814fd4ffeef52385295
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SCN8A SYN2 GRIA2 PEX5L	2.10e-04	186	70	4	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NWD2 SCN8A SYN2 GRIA2	2.14e-04	187	70	4	7b2cd0c618ed081223343f3bec2244c8723c9a31
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FMO2 LAMA4 NFASC NCAM2	2.14e-04	187	70	4	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1E NFASC GRIA2 PEX5L	2.14e-04	187	70	4	98477ba04a42a8da80a72f41a182429f46283595
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP6V1G3 GRIA2 ATP6V0D2 PEX5L	2.18e-04	188	70	4	1f912ea015f50570e848259d948a0ba682d64bb4
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	NWD2 LAMA4 SYN2 EYA2	2.18e-04	188	70	4	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	Neuronal_cells-Schwann_cells\|World / Lineage and Cell class	NFASC NCAM2 PEX5L CNTN2	2.23e-04	189	70	4	371cdc92549269e45c23c5a5b3cae9c5d35ee217
ToppCell	Neuronal_cells\|World / Lineage and Cell class	NFASC NCAM2 PEX5L CNTN2	2.23e-04	189	70	4	3948775a0ebd4b32c1623d5487f5581e6e2934d7
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	FMO2 LAMA4 NFASC NCAM2	2.27e-04	190	70	4	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	ATP13A4 FMO2 EYA2 TTC6	2.32e-04	191	70	4	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FMO2 LAMA4 TNMD CNTN2	2.32e-04	191	70	4	5271198116343c07202649889057e5774d7fdde3
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SCN5A LAMA4 GRIA2	2.32e-04	191	70	4	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FMO2 EFS LAMA4 SYN2	2.32e-04	191	70	4	cd497abed9e00e4e0becd9dbc036c6e7a60ae791
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	ATP13A4 FMO2 EYA2 TTC6	2.32e-04	191	70	4	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD3G USP11 HPGD MGAT4A	2.32e-04	191	70	4	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 LAMA4 NFASC NCAM2	2.32e-04	191	70	4	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SCN5A LAMA4 GRIA2	2.32e-04	191	70	4	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 LAMA4 NFASC NCAM2	2.36e-04	192	70	4	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SCN8A SYN2 GRIA2	2.41e-04	193	70	4	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RCOR1 MYO9B RBM47 BIRC6	2.41e-04	193	70	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 LAMA4 NFASC NCAM2	2.41e-04	193	70	4	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	FMO2 LAMA4 NFASC NCAM2	2.41e-04	193	70	4	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SCN8A SYN2 GRIA2	2.41e-04	193	70	4	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SCN8A SYN2 GRIA2	2.41e-04	193	70	4	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FMO2 TTC28 LAMA4 NCAM2	2.41e-04	193	70	4	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FMO2 TTC28 LAMA4 NCAM2	2.46e-04	194	70	4	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NFASC PEX5L RBM47 TTC6	2.46e-04	194	70	4	b30379f8dc41c86c746af9930541fbb4819d8fa0
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	FMO2 LAMA4 NFASC NCAM2	2.51e-04	195	70	4	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	FMO2 LAMA4 NFASC NCAM2	2.51e-04	195	70	4	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFASC GRIA2 EYA2 PEX5L	2.56e-04	196	70	4	efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCell	(1)_T_CD8_MAIT\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CD3G GIMAP2 HPGD MGAT4A	2.56e-04	196	70	4	5fc99a8e3dde12fd0b0b2e0a2db48ac16b42739e
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 LAMA4 NFASC NCAM2	2.56e-04	196	70	4	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer\|World / Primary Cells by Cluster	CACNA1E GRIA2 NCAM2 EYA2	2.61e-04	197	70	4	41e823b14697827f657b13adb3afa581bd91a9cb
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	NFASC GRIA2 EYA2 CNTN2	2.61e-04	197	70	4	c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	FMO2 LAMA4 NFASC NCAM2	2.61e-04	197	70	4	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	DGLUCY CD3G GIMAP2 RAD50	2.61e-04	197	70	4	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	lymphoid-T_cell\|lymphoid / Lineage, cell class and subclass	CD3G GIMAP2 HPGD MGAT4A	2.66e-04	198	70	4	41573038b34803f664a7cb5a7d05b8afdff55b58
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 FMO2 EYA2 TTC6	2.66e-04	198	70	4	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SCN8A SYN2 GRIA2 PEX5L	2.66e-04	198	70	4	8f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	FMO2 LAMA4 NFASC NCAM2	2.66e-04	198	70	4	2d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP13A4 FMO2 RBM47 TTC6	2.66e-04	198	70	4	5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 FMO2 EYA2 TTC6	2.66e-04	198	70	4	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SCN8A SYN2 GRIA2 PEX5L	2.66e-04	198	70	4	e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 LAMA4 NFASC NCAM2	2.66e-04	198	70	4	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 RBM47 TTC6 LRP2BP	2.71e-04	199	70	4	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	ENO4 CD3G FMO2 WDR89	2.71e-04	199	70	4	cf592d93612023a13de21e0fb8c6b13714f9af71
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	PHPT1 TRAPPC3L NCAM2 SSBP1	2.71e-04	199	70	4	eb5971660dff356721a004f821d52a5b7a33c951
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1E STRN RBM47 TTC6	2.76e-04	200	70	4	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFASC NCAM2 PEX5L CNTN2	2.76e-04	200	70	4	56f1f007ba8c9188a4b10e52744f1e50dc0f155a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	a510deaada669e690329183e18df02870bd204b3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E TTC28 GRIA2 ACVR2A	2.76e-04	200	70	4	19055194a5e0ea122f1b8fc62df44813f6843c95
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NWD2 GRIA2 GRIA4 TTC6	2.76e-04	200	70	4	0f23e72649a274043bf23e0952a9b5707c516acf
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FMO2 LAMA4 NFASC NCAM2	2.76e-04	200	70	4	dd4228cbed8a4395166a6332e08d44d88bebe3b9
Drug	AC1N3UXZ	AMY1A AMY1B AMY1C	2.78e-08	3	70	3	CID004118625
Drug	KSCN	AMY1A AMY1B AMY1C GRIA2 GRIA4	9.59e-08	37	70	5	CID000516872
Drug	2-nitropropyl acetate	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID013573844
Drug	N-PMT	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID000194224
Drug	Dembrexine	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID000072009
Drug	g lw	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID000444139
Drug	AC1MQT4V	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID003482066
Drug	beta-santalene	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID000010534
Drug	SAIB-SG	AMY1A AMY1B AMY1C	1.11e-07	4	70	3	CID002735139
Drug	actinidine	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID000068231
Drug	Deposiston	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID003080829
Drug	2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID010358258
Drug	2TAA	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID000127374
Drug	cimicifugic acid A	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID006449879
Drug	silver perchlorate	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID000024562
Drug	lunularic acid	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID000161413
Drug	himachalene	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID000015095
Drug	AC1L4DZ4	AMY1A AMY1B AMY1C	2.77e-07	5	70	3	CID000155287
Drug	4,6-O-3-ketobutylidene maltopentaose	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID003083414
Drug	2-amino-6-picoline	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000015765
Drug	phenol blue	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000075078
Drug	R 623	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID003027594
Drug	Gu-4	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000448679
Drug	dimethylaminomethylferrocene	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000102082
Drug	mono-6-deoxy-6-fluorocyclomaltoheptaose	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000127364
Drug	(2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID009577343
Drug	Borane dimethylamine complex	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID009898794
Drug	AC1L3OV4	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000092801
Drug	CNP-G3	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID003082910
Drug	AC1OAGH8	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID006857368
Drug	vermella	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000203726
Drug	hymenin	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000010499
Drug	tris(hydroxyethyl)aminomethane	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000448009
Drug	mercuric thiocyanate	AMY1A AMY1B AMY1C	5.53e-07	6	70	3	CID000011615
Drug	3KBG5CNP	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID003083250
Drug	AC1L9UU3	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID000071762
Drug	AC1L5BOU	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID000174858
Drug	Paramax	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID000156411
Drug	BG5P	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID003082752
Drug	methyl blue	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID011969534
Drug	amino-methyl	AMY1A AMY1B AMY1C	9.66e-07	7	70	3	CID000142005
Drug	NSC82626	LIG4 AMY1A AMY1B AMY1C ACR MMP20	1.07e-06	109	70	6	CID000000645
Drug	boric acid gel	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID003016474
Drug	AC1NSVJM	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID005317411
Drug	theodrenaline	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000071857
Drug	N-vinylcaprolactam	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000075227
Drug	9-azidoacridine	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000146692
Drug	acrinor	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID005489637
Drug	Triap	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000013356
Drug	rhodanile blue	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000073372
Drug	desethylaprophen	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000163919
Drug	azintamide	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000071105
Drug	NSC300622	AMY1A AMY1B AMY1C	1.54e-06	8	70	3	CID000028426
Drug	Atonik	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID000069471
Drug	GSAD	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID009909127
Drug	GU-3	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID000448687
Drug	alpha-maltosyl fluoride	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID000194237
Drug	trestatin A	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID003054994
Drug	zingiberene	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID000092776
Drug	H 187	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID000001742
Drug	mercuric nitrate	AMY1A AMY1B AMY1C	2.31e-06	9	70	3	CID000024864
Drug	B5-9	AMY1A AMY1B AMY1C NAE1	2.76e-06	32	70	4	CID003001978
Drug	R625	AMY1A AMY1B AMY1C ACR	3.13e-06	33	70	4	CID000072375
Drug	AC1LAC07	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000485275
Drug	I ZE	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID009549200
Drug	Glc)4	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000189098
Drug	trans-cinnamamide	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000012135
Drug	CG-120	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000171403
Drug	Ro 20-0083	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID003082332
Drug	naphthalene-1,3,6,8-tetrol	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000440202
Drug	AC1L3M0Q	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000118008
Drug	eicosa-11,14-dienoic acid	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000003208
Drug	UDP-pyridoxal	AMY1A AMY1B AMY1C	3.29e-06	10	70	3	CID000126789
Drug	validamycin D	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000166726
Drug	AMO-1618	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000017103
Drug	FG5P	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000127486
Drug	AC1L8PXO	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000430710
Drug	CNP-G5	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000127309
Drug	Tempamine	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000550942
Drug	HgI2	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000024485
Drug	L-tert-leucine	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID000164608
Drug	2C KM	AMY1A AMY1B AMY1C	4.51e-06	11	70	3	CID009549196
Drug	chitosan	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000071853
Drug	azaprophen	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000129486
Drug	Avenin	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000095924
Drug	AC1L4W0B	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000193311
Drug	3-hydr-oxy-2-naphthohydrazide	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000072699
Drug	H2folate	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000168809
Drug	chloroisocyanuric acid	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000017921
Drug	CTK2H7378	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID005462310
Drug	glyciphosphoramide	AMY1A AMY1B AMY1C	6.00e-06	12	70	3	CID000197092
Drug	GA15	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000443453
Drug	dibromopropanol	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000007281
Drug	AC1L9AGE	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000441043
Drug	AC1NTMU5	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID003035508
Drug	8a-c	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000066085
Drug	II 13	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID003040488
Drug	maltal	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000169427
Drug	pie-like	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000017384
Drug	methyl 1'-epiacarviosin	AMY1A AMY1B AMY1C	7.79e-06	13	70	3	CID000197426
Disease	epilepsy (implicated_via_orthology)	CACNA1E SCN5A SCN8A SYN2 NFASC	3.54e-05	163	67	5	DOID:1826 (implicated_via_orthology)
Disease	contactin-2 measurement	NFASC CNTN2	7.57e-05	6	67	2	EFO_0008100
Disease	reticulocyte count	STRN RCOR1 ATP6V1G3 PELO MYO9B LAMA4 SYN2 EYA2 BIRC6 GGCX	1.18e-04	1045	67	10	EFO_0007986
Disease	biological sex	LIG4 ZNF280D TTC28 NFASC PEX5L	1.80e-04	230	67	5	PATO_0000047
Disease	alpha-amylase 1 measurement	AMY1A AMY1C	1.81e-04	9	67	2	EFO_0801371
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN5A SCN8A	2.26e-04	10	67	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN5A SCN8A	2.26e-04	10	67	2	DOID:0080422 (implicated_via_orthology)
Disease	allergic rhinitis	LAMA4 EYA2 TTC6 RAD50	2.43e-04	133	67	4	EFO_0005854
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN5A SCN8A	3.30e-04	12	67	2	DOID:0060170 (implicated_via_orthology)
Disease	waist-hip ratio	IPPK DGLUCY MMS22L ZNF280D TTC28 MYO9B LAMA4 EYA2 BIRC6 CNTN2	4.25e-04	1226	67	10	EFO_0004343
Disease	central nervous system disease (implicated_via_orthology)	GRIA2 GRIA4	5.97e-04	16	67	2	DOID:331 (implicated_via_orthology)
Disease	coffee consumption measurement	MMS22L PCMTD2 EYA2 BIRC6	7.93e-04	182	67	4	EFO_0006781
Disease	Primary familial dilated cardiomyopathy	SCN5A LAMA4	2.12e-03	30	67	2	cv:C0340427

Protein segments in the cluster

Peptide	Gene	Start	Entry
IQELNGHYNKYMESV	ATP6V1G3	81	Q96LB4
IMLVNDFYYGKHEGD	ZNF280D	296	Q6N043
KGNHLVKVYDYQEDG	CD3G	26	P09693
DEDGKLGFKVNYHYM	BIRC6	4546	Q9NR09
GNYVDHEKNKMEVKG	CACNA1E	1331	Q15878
KGKTYSDGKNHYDME	ACR	396	P10323
VEEKKHIMYGNQDNY	ATP13A4	761	Q4VNC1
NEYEVYSLPGMKHEN	ACVR2A	231	P27037
GKDYVRSKIAEYMNH	AMY1B	186	P0DTE7
GKDYVRSKIAEYMNH	AMY1C	186	P0DTE8
GKDYVRSKIAEYMNH	AMY1A	186	P0DUB6
NHYIEGLGKQFYEDM	NWD2	336	Q9ULI1
EYIAIAKEKHGYNME	RCOR1	151	Q9UKL0
YHEGKGKQQEKGYEL	RBM47	411	A0AV96
VKNIHGYMKDIENYI	RAD50	951	Q92878
GYMKDIENYIQDGKD	RAD50	956	Q92878
NVMKEFLGENYVHYG	IPPK	61	Q9H8X2
KVYQGHTLEKTYMGE	MGAT4A	401	Q9UM21
YFKMHDYDGNNLLDG	MCFD2	76	Q8NI22
EKENYHYVTILMKGE	NUDT15	86	Q9NV35
YMLGEKLKQVVYGHQ	MMS22L	226	Q6ZRQ5
KNHEMLEGNERYEGY	GRIA2	431	P42262
KKNHEMFEGNDKYEG	GRIA4	431	P48058
GAGVQKEHEEYMKNL	PCMTD2	166	Q9NV79
MYQGHMQKSKEQGYG	PEX5L	1	Q8IYB4
KMGQIIQYDKFYIHE	HERC4	606	Q5GLZ8
KEKDHQATYQLGVMY	LRP2BP	86	Q9P2M1
KMAQNGLDHYVYKVG	HELZ	336	P42694
IKYAKYMENHSIEGV	PRPF39	391	Q86UA1
SQSGHEYDPINYMKK	RBBP6	136	Q7Z6E9
GNYHVYENGSLEIKM	NFASC	476	O94856
GYDEIDNGYLKMDNH	ACOX1	231	Q15067
AYMKETYHRINEGIG	ACOX1	346	Q15067
NDDILQKIKYYMGHS	ARMC8	596	Q8IUR7
MHKDGDVYKYFSRNG	LIG4	281	P49917
LMEKNGDHYTNGLYS	GIMAP2	206	Q9UG22
EEGKNHMYLFEGKDY	CHD1L	566	Q86WJ1
PKMYDLQYQGGHKEA	CBX4	166	O00257
IIIHDQYKMAESGYD	F11	466	P03951
GMYQCVAENKHGTIY	CNTN2	391	Q02246
YDYVHLKGMDKAQGS	EFS	381	O43281
NCAGHELMDYNKGKY	ENO4	396	A6NNW6
HENYGLEPQNKYIMK	FMO2	266	Q99518
ADGNYYNARKMNIKH	DGLUCY	441	Q7Z3D6
QLKGEVAQMAAYYEH	RFC3	306	P40938
QEINNKMLYYGEEHE	LAMA4	396	Q16363
DKYYTNKEGHQIGEM	MMP20	46	O60882
KEENMGQYIEYKDHI	HPGD	196	P15428
RVKEMYNTYKNNVGG	EYA2	386	O00167
GMGKVKVENHYDFQD	SYN2	276	Q92777
YHKLKYGTELNQGDM	STRN	116	O43815
GGQDIFMTEEQKKYY	SCN5A	1481	Q14524
TNIQENEYVKMGAYH	PELO	86	Q9BRX2
EYHADIYDKVSGDMQ	PHPT1	51	Q9NRX4
HGEDYKAMARDEKNY	NOP16	126	Q9Y3C1
QGTVEKDKEMYHDYI	SIX6OS1	101	Q8N1H7
KAGYQDMPEYENFKH	SEC23B	671	Q15437
AYDMEHTFYSNGEKK	TNMD	61	Q9H2S6
GEKMQLPAGEYHKVY	GGCX	576	P38435
HEYSHYKEQDGQGMK	UNC93B1	191	Q9H1C4
GNSYMEYGHDEATKQ	TTC6	251	Q86TZ1
IGGHQKSMYLDIEYA	NCAM2	386	O15394
EGKIDYGEYMDKNNV	SSBP1	111	Q04837
KLIMHNKADYAYNGG	UNC119B	236	A6NIH7
GQDIFMTEEQKKYYN	SCN8A	1476	Q9UQD0
MIQKYDKALGYHTQE	TTC28	766	Q96AY4
KDEDVNQYLDKMGYG	TRAPPC3L	36	Q5T215
GKGYKQIYCMTHDEG	WDR89	226	Q96FK6
QEYGLSVMVKDDYVH	NAE1	466	Q13564
AEGYVKHDCVGYVMK	USP11	761	P51784
KHQIVHMGGKSYDYN	ZNF248	341	Q8NDW4
FDQMKNVADHYGVYK	ATP6V0D2	261	Q8N8Y2
GKIHVGYKDLMENYQ	MYO9B	1556	Q13459